Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Nabriva Therapeutics plc (NBRV) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 5 shares @ $1.3, valued at $6.5
01/10/2023 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 11 shares @ $1.3, valued at $14.3
01/04/2023 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 5 shares @ $1.89, valued at $9.5
01/04/2023 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3 shares @ $1.89, valued at $5.7
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/08/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4 shares @ $2.2392, valued at $9
11/08/2022 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 10 shares @ $2.2392, valued at $22.4
11/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 9 shares @ $2.72, valued at $24.5
10/11/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4 shares @ $2.72, valued at $10.9
10/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2022 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 5 shares @ $2.08, valued at $10.4
09/07/2022 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 225 shares @ $0.1566, valued at $35.2
09/07/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 89 shares @ $0.1566, valued at $13.9
09/01/2022 4 Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 107 shares @ $0.1646, valued at $17.6
09/01/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 61 shares @ $0.1646, valued at $10
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Exercised 93,400 options to buy @ $0.45, valued at $42k
Exercised 46,700 restricted stock units @ $0
Exercised 93,400 rights @ $0.45, valued at $42k
Exercised 46,700 options to buy @ $0
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Dolan Daniel (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Exercised 83,200 options to buy @ $0.45, valued at $37.4k
Exercised 41,600 restricted stock units @ $0
Exercised 83,200 rights @ $0.45, valued at $37.4k
Exercised 41,600 options to buy @ $0
08/15/2022 4 Guico-Pabia Christine J. (Chief Medical Officer) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Exercised 71,500 options to buy @ $0.45, valued at $32.2k
Exercised 35,700 restricted stock units @ $0
Exercised 71,500 rights @ $0.45, valued at $32.2k
Exercised 35,700 options to buy @ $0
08/08/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 89 shares @ $0.1847, valued at $16.4
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2022 4 Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Sold 8,496 shares @ $0.175, valued at $1.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy